Literature DB >> 25751371

Gastroesophageal Reflux Disease: Cross-Sectional Study Demonstrating Rising Prevalence in a Chinese Population.

Victoria Ping-Yi Tan1, Benjamin ChunYu Wong, Wai Man Wong, Wai Keung Leung, Daniel Tong, Man Fung Yuen, Ronnie Fass.   

Abstract

BACKGROUND AND AIMS: The prevalence of gastroesophageal reflux disease (GERD) is consistently lower in the Chinese than in white populations. Population-based data tracking the time trend of GERD prevalence in Chinese subjects is conflicting. This study examines the population prevalence, risk factors, and time trend associated with GERD in a Chinese population.
METHODS: A population-based cross-sectional study utilizing a validated GERD questionnaire administered by a telephone survey was performed on 3360 Chinese subjects from Hong Kong. GERD prevalence rates in 2011 were compared with prevalence rates in 2002 and 2006. Multiple logistic regressions were performed to determine the risk factors associated with weekly GERD.
RESULTS: A total of 2074 subjects (mean age, 48.1±18.2 y; range 18 to 94; 63.1% female) completed the survey (response rate 61.7%). The prevalence of GERD as defined by the Montreal definition was 3.8%. The prevalence of weekly GERD had increased by 1.3% between 2002 and 2011, which represents an at least 50% relative increase (P<0.0005). A diagnosis of weekly GERD was associated with noncardiac chest pain [odds ratio (OR), 1.7; 95% confidence interval (CI), 1.034-2.9; P=0.037], dyspepsia (OR, 5.1; 95% CI, 3.0-8.8; P<0.005), and an acid feeling in the stomach (OR, 3.0; 95% CI, 1.8-5.1).
CONCLUSIONS: GERD rates in the ethnic Chinese have risen over the last decade. Despite this, variables associated with a survey diagnosis of GERD remain ostensibly unchanged. GERD research in East Asia should focus on the factors driving the rapid rise in prevalence rates and the association with more atypical symptoms of GERD.

Entities:  

Mesh:

Year:  2016        PMID: 25751371     DOI: 10.1097/MCG.0000000000000304

Source DB:  PubMed          Journal:  J Clin Gastroenterol        ISSN: 0192-0790            Impact factor:   3.062


  11 in total

1.  Associations among gastroesophageal reflux disease, mental disorders, sleep and chronic temporomandibular disorder: a case-control study.

Authors:  Yuanyuan Li; Ming Fang; Lina Niu; Yu Fan; Yan Liu; Yong Long; Xiaodong Liu; Franklin R Tay; Jihua Chen
Journal:  CMAJ       Date:  2019-08-19       Impact factor: 8.262

2.  Health-related quality of life in gastroesophageal reflux patients with noncardiac chest pain: Emphasis on the role of psychological distress.

Authors:  Lei Zhang; Lei Tu; Jie Chen; Jun Song; Tao Bai; Xue-Lian Xiang; Rui-Yun Wang; Xiao-Hua Hou
Journal:  World J Gastroenterol       Date:  2017-01-07       Impact factor: 5.742

Review 3.  Current Status and Future Directions of Chronic Cough in China.

Authors:  Kefang Lai; Li Long
Journal:  Lung       Date:  2020-01-07       Impact factor: 2.584

4.  [Esophageal pH-impedance monitoring of reflux patterns in non-erosive reflux disease, reflux hypersensitivity and functional heartburn].

Authors:  Ajing Zhang; Wenzhu Yao; Jia Di; Manli Cui; Mingxin Zhang; Jun Zhang
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2020-10-30

5.  Prevalence of gastroesophageal reflux disease: a population-based cross-sectional study in southern Chile.

Authors:  Carlos Manterola; Luis Grande; Luis Bustos; Tamara Otzen
Journal:  Gastroenterol Rep (Oxf)       Date:  2020-02-19

6.  Clinicopathological Features and Increased Expression of Toll-Like Receptor 4 of Gastric Cardia Cancer in a High-Risk Chinese Population.

Authors:  Guangcan Chen; Muming Xu; Jingyao Chen; Liangli Hong; Wenting Lin; Shukun Zhao; Guohong Zhang; Guo Dan; Shuhui Liu
Journal:  J Immunol Res       Date:  2018-02-18       Impact factor: 4.818

7.  Lifestyle intervention for gastroesophageal reflux disease: a national multicenter survey of lifestyle factor effects on gastroesophageal reflux disease in China.

Authors:  Ling-Zhi Yuan; Ping Yi; Gang-Shi Wang; Shi-Yun Tan; Guang-Ming Huang; Ling-Zhi Qi; Yan Jia; Fen Wang
Journal:  Therap Adv Gastroenterol       Date:  2019-09-25       Impact factor: 4.409

8.  Phase III, randomised, double-blind, multicentre study to evaluate the efficacy and safety of vonoprazan compared with lansoprazole in Asian patients with erosive oesophagitis.

Authors:  Yinglian Xiao; Shutian Zhang; Ning Dai; Guijun Fei; Khean-Lee Goh; Hoon Jai Chun; Bor-Shyang Sheu; Chui Fung Chong; Nobuo Funao; Wen Zhou; Minhu Chen
Journal:  Gut       Date:  2019-08-13       Impact factor: 23.059

9.  Prevalence and Correlates of Gastroesophageal Reflux Disease in Southern Iran: Pars Cohort Study.

Authors:  Zohre Khodamoradi; Abdullah Gandomkar; Hossein Poustchi; Alireza Salehi; Mohammad Hadi Imanieh; Arash Etemadi; Reza Malekzadeh
Journal:  Middle East J Dig Dis       Date:  2017-07

10.  Efficacy of DA-5204 (Stillen 2X) for patients with gastroesophageal reflux disease: A randomized, double-blind, placebo-controlled pilot study.

Authors:  Jae Ho Cho; Hyuk Yoon; Cheol Min Shin; Young Soo Park; Nayoung Kim; Dong Ho Lee
Journal:  Medicine (Baltimore)       Date:  2020-10-30       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.